232 related articles for article (PubMed ID: 28498423)
1. PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells.
Ye M; Li J; Gong J
Oncol Rep; 2017 Jun; 37(6):3167-3174. PubMed ID: 28498423
[TBL] [Abstract][Full Text] [Related]
2. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
5. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
[TBL] [Abstract][Full Text] [Related]
7. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
9. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Chen J; Chen Z; Huang Z; Yu H; Li Y; Huang W
Med Sci Monit; 2019 Jun; 25():4474-4484. PubMed ID: 31203308
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
Wang X; Han L; Zhang J; Xia Q
Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
[TBL] [Abstract][Full Text] [Related]
11. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
Han L; Wang Y; Sun S
Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759
[TBL] [Abstract][Full Text] [Related]
13. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
14. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
[TBL] [Abstract][Full Text] [Related]
15. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
Liu H; Li W; Chen C; Pei Y; Long X
Tumour Biol; 2015 Aug; 36(8):6313-9. PubMed ID: 25804796
[TBL] [Abstract][Full Text] [Related]
16. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
Sui Y; Zheng X; Zhao D
Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J
Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051
[TBL] [Abstract][Full Text] [Related]
19. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
Zhang Z; Zhu J; Huang Y; Li W; Cheng H
Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
